Metabolic syndrome may increase prostate cancer risk

07/5/2013 | Renal and Urology News

Men with three or more metabolic syndrome components were 38% more likely than those with no risk factors to be diagnosed with prostate cancer and had a 52% higher risk of clinically significant prostate cancer and a 43% higher risk of high-grade prostate cancer, a Canadian study showed. The findings were presented at the Canadian Urological Association's 2013 meeting.

View Full Article in:

Renal and Urology News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT